PT745388E - Composicao de vacinas para mamiferos compreendendo esqualeno ou esqualano fosfolipido e um tensioactivo como adjevante - Google Patents

Composicao de vacinas para mamiferos compreendendo esqualeno ou esqualano fosfolipido e um tensioactivo como adjevante

Info

Publication number
PT745388E
PT745388E PT96303930T PT96303930T PT745388E PT 745388 E PT745388 E PT 745388E PT 96303930 T PT96303930 T PT 96303930T PT 96303930 T PT96303930 T PT 96303930T PT 745388 E PT745388 E PT 745388E
Authority
PT
Portugal
Prior art keywords
phospholidic
eschalene
eschalane
tensioactive
comprehending
Prior art date
Application number
PT96303930T
Other languages
English (en)
Inventor
Richard Norman Hjorth
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23825442&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT745388(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT745388E publication Critical patent/PT745388E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PT96303930T 1995-06-02 1996-05-31 Composicao de vacinas para mamiferos compreendendo esqualeno ou esqualano fosfolipido e um tensioactivo como adjevante PT745388E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/459,602 US5690942A (en) 1995-06-02 1995-06-02 Adjuvants for viral vaccines

Publications (1)

Publication Number Publication Date
PT745388E true PT745388E (pt) 2002-11-29

Family

ID=23825442

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96303930T PT745388E (pt) 1995-06-02 1996-05-31 Composicao de vacinas para mamiferos compreendendo esqualeno ou esqualano fosfolipido e um tensioactivo como adjevante

Country Status (13)

Country Link
US (1) US5690942A (pt)
EP (1) EP0745388B2 (pt)
JP (1) JP4249807B2 (pt)
KR (1) KR970000249A (pt)
AT (1) ATE222504T1 (pt)
AU (1) AU710499B2 (pt)
CA (1) CA2177667C (pt)
DE (1) DE69623072T3 (pt)
DK (1) DK0745388T4 (pt)
ES (1) ES2180703T5 (pt)
HU (1) HUP9601462A2 (pt)
NZ (1) NZ286700A (pt)
PT (1) PT745388E (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
CA2290078C (en) * 1999-01-29 2013-01-22 Pfizer Products Inc. Erysipelothrix rhusiopathiae antigens and vaccine compositions
AT407958B (de) * 1999-02-11 2001-07-25 Immuno Ag Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
US7632929B2 (en) * 2000-04-20 2009-12-15 The Board Of Trustees Of The University Of Arkansas Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
WO2004087204A2 (en) * 2003-04-04 2004-10-14 Pfizer Products Inc. Microfluidized oil-in-water emulsions and vaccine compositions
ES2409782T3 (es) 2004-04-05 2013-06-27 Zoetis P Llc Emulsiones de aceite en agua microfluidificadas y composiciones de vacuna
JP2007532666A (ja) 2004-04-14 2007-11-15 アヴィリッド インコーポレーテッド ウイルス核酸を対象とした修飾ヌクレアーゼを用いた組成物及びウイルス性疾患の予防並びに治療方法
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
ES2619647T3 (es) * 2007-04-20 2017-06-26 Bioventures Llc Compuestos de hapteno y composiciones y usos de los mismos
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
GB0801122D0 (en) * 2008-01-22 2008-02-27 Avecia Biolog Ltd Vaccine composition
CA2738621C (en) 2008-10-02 2017-01-31 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
GB0917887D0 (en) * 2009-10-13 2009-11-25 Milan Guy D Temperature sensitive packaging closures
US9023353B2 (en) 2013-03-13 2015-05-05 The Board Of Trustees Of The University Of Arkansas Anti-(+)—methamphetamine monoclonal antibodies
CN104208029B (zh) * 2013-05-30 2017-06-06 上海医药工业研究院 一种鼻用疫苗组合物粉体制剂及其制备方法
EP3116541B1 (en) 2014-03-12 2019-11-27 Bavarian Nordic A/S Use of oil and water emulsions for increasing b cell responses with modified vaccinia ankara virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1163470A (en) * 1967-11-13 1969-09-04 Cecil Arthur Clark Improvements in or relating to Adjuvant Vaccines
US4466957A (en) * 1982-02-25 1984-08-21 American Home Products Corporation Vaccine adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
FR2649012B1 (fr) † 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
FR2649013B1 (fr) † 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
WO1993024147A1 (en) † 1992-05-29 1993-12-09 Smithkline Beecham Corporation Lecithin adjuvanted modified live virus vaccines
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
HUP9601462A2 (en) 1997-03-28
CA2177667A1 (en) 1996-12-03
JP4249807B2 (ja) 2009-04-08
ES2180703T5 (es) 2007-04-01
KR970000249A (ko) 1997-01-21
EP0745388A1 (en) 1996-12-04
AU710499B2 (en) 1999-09-23
EP0745388B2 (en) 2006-08-30
DE69623072T3 (de) 2007-03-29
NZ286700A (en) 1997-10-24
US5690942A (en) 1997-11-25
JPH08325162A (ja) 1996-12-10
DE69623072T2 (de) 2002-12-19
DK0745388T3 (da) 2002-12-02
ATE222504T1 (de) 2002-09-15
DK0745388T4 (da) 2007-01-08
AU5457496A (en) 1996-12-12
ES2180703T3 (es) 2003-02-16
HU9601462D0 (en) 1996-07-29
EP0745388B1 (en) 2002-08-21
DE69623072D1 (de) 2002-09-26
CA2177667C (en) 2008-06-17

Similar Documents

Publication Publication Date Title
PT745388E (pt) Composicao de vacinas para mamiferos compreendendo esqualeno ou esqualano fosfolipido e um tensioactivo como adjevante
DE69634024D1 (de) Adjuvans für vitale Impfstoffe
DK1113816T3 (da) Influenzavirus-vaccinesammensætning
ATE249844T1 (de) Immunologische kombinationsmittel und dazugehörige verfahren
AU1766295A (en) Swine pneumonia vaccine and method for the preparation thereof
DK0656883T3 (da) Kationiske lipider
ES2157447T3 (es) Composicion de vacuna que comprende un antigeno de polisacarido conjugado adsorbido en fosfato de aluminio.
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
AR023000A1 (es) Agentes tensioactivos para uso en formulaciones para la agricultura
DE69833260D1 (de) Zusammensetzung mit alpha-glycosylceramid zur stärkung zellulärer immunogenität
UA50808C2 (uk) Композиція для лікування респіраторного дистрес-синдрому дорослих або респіраторного дистрес-синдрому новонароджених
DK0799613T3 (da) Beholder med frysetørrede vaccinekomponenter
DK0939648T3 (da) Rotavirusvaccineformuleringer
PT789590E (pt) Imunopotenciacao induzida por quitosano
BR9914787A (pt) Processo para a preparação de um composto
PT792165E (pt) Composicoes imunogenicas
WO1999047101A3 (en) Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
BR9914004A (pt) Composições imunogênicas de lipossomas
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
AU4537100A (en) Adjuvant combinations for immunization composition and vaccines
CA2255867A1 (en) Chitosan induced immunopotentiation
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner